ColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal cancer

Colorectal cancer (CRC) is the third leading cause of cancer mortality worldwide. Different pathological pathways and molecular drivers have been described and some of the associated markers are used to select effective anti-neoplastic therapy. More recent evidence points to a causal role of microbi...

Full description

Saved in:
Bibliographic Details
Published inScientific data Vol. 6; no. 1; pp. 255 - 14
Main Authors Esteban-Gil, Angel, Pérez-Sanz, Fernando, García-Solano, José, Alburquerque-González, Begoña, Parreño-González, María Antonia, Legaz-García, María del Carmen, Fernández-Breis, Jesualdo Tomás, Rodriguez-Braun, Edith, Pimentel, Paola, Tuomisto, Anne, Mäkinen, Markus, Slaby, Ondrej, Conesa-Zamora, Pablo
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 31.10.2019
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Colorectal cancer (CRC) is the third leading cause of cancer mortality worldwide. Different pathological pathways and molecular drivers have been described and some of the associated markers are used to select effective anti-neoplastic therapy. More recent evidence points to a causal role of microbiota and altered microRNA expression in CRC carcinogenesis, but their relationship with pathological drivers or molecular phenotypes is not clearly established. Joint analysis of clinical and omics data can help clarify such relations. We present ColPortal, a platform that integrates transcriptomic, microtranscriptomic, methylomic and microbiota data of patients with colorectal cancer. ColPortal also includes detailed information of histological features and digital histological slides from the study cases, since histology is a morphological manifestation of a complex molecular change. The current cohort consists of Caucasian patients from Europe. For each patient, demographic information, location, histology, tumor staging, tissue prognostic factors, molecular biomarker status and clinical outcomes are integrated with omics data. ColPortal allows one to perform multiomics analyses for groups of patients selected by their clinical data. Measurement(s) miRNA • methylation • clinical history • histology • transcription profiling assay • microbiome Technology Type(s) DNA sequencing • clinical monitoring • RNA sequencing • amplicon sequencing • ex vivo photography with digital image analysis • methylation profiling by array Factor Type(s) tumor status Sample Characteristic - Organism Homo sapiens Machine-accessible metadata file describing the reported data: https://doi.org/10.6084/m9.figshare.9785795
ISSN:2052-4463
2052-4463
DOI:10.1038/s41597-019-0198-z